BIOSUPERFICIES Y BIOMATERIALES

Limited association between central pain processing and clinical outcomes in non-specific chronic neck pain after a manual therapy intervention: A secondary analysis.

Zabala-Mata, J, Azkue, JJ, Bialosky, JE, López-Dominguez, E, de Jauregui, DRF, Lascurain-Aguirrebeña, I.

MUSCULOSKELETAL SCIENCE AND PRACTICE, 77, 0-0 (2025)

DOI: 10.1016/j.msksp.2025.103323

Hydrophobically-modified hyaluronic acid as stabilizer for oil-in-water emulsions to improve epidermis biodistribution of actives.

Zamora, P, Movellan, J, Grande, HJ, Loinaz, I, Dupin, D.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 330, 0-0 (2025)

DOI: 10.1016/j.ijbiomac.2025.148329

Tobramycin nanoformulation for chronic pulmonary infections: From drug product definition to scale-up for preclinical evaluation.

Movellan, J, Murgia, X, Gracia, R, Marradi, M, Miranda, JI, Aizpurua, JM, Grande, HJ, Dupin, D, Loinaz, I.

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 671, 125241-125241 (2025)

DOI: 10.1016/j.ijpharm.2025.125241

Manual therapy and neck-specific exercise are equally effective for treating non-specific neck pain but only when exercise adherence is maximised: A randomised controlled trial..

Villanueva-Ruiz I, Falla D, Saez M, Araolaza-Arrieta M, Azkue JJ, Arbillaga-Etxarri A, Lersundi A, Lascurain-Aguirrebeña I.

MUSCULOSKELETAL SCIENCE AND PRACTICE, 77, 103319-103319 (2025)

DOI: 10.1016/j.msksp.2025.103319

Are baseline clinical tests associated with the relative effectiveness of manual therapy and neck-specific exercise for people with chronic non-specific neck pain? Secondary analysis of a randomized controlled trial.

Villanueva-Ruiz, I, Falla, D, Saez, M, Araolaza-Arrieta, M, Azkue, JJ, Arbillaga-Etxarri, A, Lersundi, A, Lascurain-Aguirrebena, I.

MUSCULOSKELETAL SCIENCE AND PRACTICE, 80, 0-0 (2025)

DOI: 10.1016/j.msksp.2025.103393

Effectiveness of neural mobilisation for the treatment of nerve-related cervicobrachial pain: a systematic review with subgroup meta-analysis.

Lascurain-Aguirrebeña I, Dominguez L, Villanueva-Ruiz I, Ballesteros J, Rueda-Etxeberria M, Rueda JR, Casado-Zumeta X, Araolaza-Arrieta M, Arbillaga-Etxarri A, Tampin B.

Pain, 165, 537-549 (2024)

DOI: 10.1097/j.pain.0000000000003071

Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studies..

Delvenne A, Vandendriessche C, Gobom J, Burgelman M, Dujardin P, De Nolf C, Tijms BM, Teunissen CE, Schindler SE, Verhey F, Ramakers I, Martinez-Lage P, Tainta M, Vandenberghe R, Schaeverbeke J, Engelborghs S, De Roeck E, Popp J, Peyratout G, Tsolaki M, Freund-Levi Y, Lovestone S, Streffer J, Bertram L, Blennow K, Zetterberg H, Visser PJ, Vandenbroucke RE, Vos SJB.

Fluids and Barriers of the CNS, 21, 58-58 (2024)

DOI: 10.1186/s12987-024-00555-3

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease..

Delvenne A, Gobom J, Schindler SE, Kate MT, Reus LM, Dobricic V, Tijms BM, Benzinger TLS, Cruchaga C, Teunissen CE, Ramakers I, Martinez-Lage P, Tainta M, Vandenberghe R, Schaeverbeke J, Engelborghs S, Roeck E, Popp J, Peyratout G, Tsolaki M, Freund-Levi Y, Lovestone S, Streffer J, Barkhof F, Bertram L, Blennow K, Zetterberg H, Visser PJ, Vos SJB.

ALZHEIMERS & DEMENTIA, 20, 6205-6220 (2024)

DOI: 10.1002/alz.14103

Blood-based multivariate methylation risk score for cognitive impairment and dementia..

Koetsier J, Cavill R, Reijnders R, Harvey J, Homann J, Kouhsar M, Deckers K, Köhler S, Eijssen LMT, van den Hove DLA, Demuth I, Düzel S, Smith RG, Smith AR, Burrage J, Walker EM, Shireby G, Hannon E, Dempster E, Frayling T, Mill J, Dobricic V, Johannsen P, Wittig M, Franke A, Vandenberghe R, Schaeverbeke J, Freund-Levi Y, Frölich L, Scheltens P, Teunissen CE, Frisoni G, Blin O, Richardson JC, Bordet R, Engelborghs S, de Roeck E, Martinez-Lage P, Tainta M, Lleó A, Sala I, Popp J, Peyratout G, Verhey F, Tsolaki M, Andreasson U, Blennow K, Zetterberg H, Streffer J, Vos SJB, Lovestone S, Visser PJ, Lill CM, Bertram L, Lunnon K, Pishva E.

ALZHEIMERS & DEMENTIA, 20, 6682-6698 (2024)

DOI: 10.1002/alz.14061

Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study..

Smith RG, Pishva E, Kouhsar M, Imm J, Dobricic V, Johannsen P, Wittig M, Franke A, Vandenberghe R, Schaeverbeke J, Freund-Levi Y, Frölich L, Scheltens P, Teunissen CE, Frisoni G, Blin O, Richardson JC, Bordet R, Engelborghs S, de Roeck E, Martinez-Lage P, Altuna M, Tainta M, Lleó A, Sala I, Popp J, Peyratout G, Winchester L, Nevado-Holgado A, Verhey F, Tsolaki M, Andreasson U, Blennow K, Zetterberg H, Streffer J, Vos SJB, Lovestone S, Visser PJ, Bertram L, Lunnon K.

ALZHEIMERS & DEMENTIA, 20, 6722-6739 (2024)

DOI: 10.1002/alz.14098